Barings BDC, Inc. quarterly report, Q1 FY2024

Barings BDC, Inc. — Q1 2024 Form 10-Q

Business context and reporting period. Barings BDC is an externally managed business development company investing primarily in senior secured private debt for middle-market businesses. This unaudited filing covers the three months ended March 31, 2024; comparisons are with Q1 2023 unless otherwise noted. Amounts below are in U.S. dollars.

Financial and portfolio highlights

MetricQ1 2024 / March 31, 2024Comparable period / prior year-end
Investment income$69.8 million$67.2 million
Net investment income after taxes$29.4 million; $0.28 per share$27.5 million; $0.25 per share
Net increase in net assets from operations$44.0 million; $0.41 per share$39.7 million; $0.37 per share
Distributions per share$0.26$0.25
Portfolio fair value$2.528 billion$2.489 billion at December 31, 2023
Net assets / NAV per share$1.212 billion / $11.44$1.197 billion / $11.28
Cash and foreign currencies$64.1 million, including $13.4 million restricted cash$70.5 million at December 31, 2023
Borrowings$440.4 million under credit facilities; $1.011 billion notes, net of financing fees$719.9 million under credit facilities; $720.6 million notes, net
Asset coverage ratio182.4%Statutory minimum referenced by the company: 150%
Unfunded financing commitments$279.8 million$305.9 million at December 31, 2023

The company reported an annualized net investment income-to-average-net-assets ratio of 9.74% and total expenses-to-average-net-assets ratio of 13.43% for Q1 2024. These are BDC financial highlights, not conventional operating margins. Operating cash flow was $4.9 million, versus cash used of $92.0 million in Q1 2023. Cash and foreign currencies declined by $6.4 million during the quarter.

Changes versus comparable periods

  • Investment income rose to $69.8 million from $67.2 million, which management attributed mainly to higher portfolio yields and increased portfolio-company and joint-venture dividends. Weighted average yield on performing debt investments was 10.7% at quarter-end, versus 10.2% at March 31, 2023.
  • Net investment income after taxes increased to $29.4 million from $27.5 million. Financing costs rose to $21.1 million from $19.3 million, primarily reflecting the new 2029 notes and a higher weighted average rate on the revolving facility. Incentive fees declined to $8.2 million from $9.6 million, mainly due to the incentive-fee cap.
  • Net realized losses increased to $21.5 million from $9.7 million. Q1 2024 included a $12.6 million net realized investment loss, primarily associated with restructurings, and a $9.1 million loss on forward currency contracts.
  • Net unrealized appreciation was $36.1 million, compared with $22.0 million. Current-portfolio appreciation was partly offset by foreign-exchange effects and lower valuations of the MVC and Sierra credit support agreements.
  • Six portfolio companies had investments on non-accrual at March 31, 2024, versus four at December 31, 2023. Their aggregate fair value was $7.9 million, compared with $37.2 million at year-end; aggregate cost was $38.1 million versus $62.6 million. New Q1 non-accruals included Canadian Orthodontic Partners, GPNZ II and Marmoutier.

Outlook, risks and unusual items

  • Management believes cash, foreign currencies, available borrowing capacity and operating cash flows will be adequate for daily operations for at least the next 12 months. No earnings or investment-yield guidance was provided.
  • In February 2024, the company issued $300 million of 7.00% senior unsecured notes due 2029, receiving approximately $292.9 million net proceeds; it used the proceeds principally to repay revolving-facility borrowings. A related $300 million interest-rate swap converts the notes’ fixed-rate exposure to a floating rate, according to the filing.
  • The company reported compliance with its credit-facility and note covenants at March 31, 2024. It had $1.065 billion of revolving-facility commitments, with a stated maturity of February 21, 2026 and the revolving period ending February 21, 2025.
  • Portfolio investments equal 208.6% of net assets, reflecting leverage. Most portfolio valuations rely on Level 3 inputs: $2.266 billion of investments measured using significant unobservable inputs. Management notes these estimates may differ materially from realizable sale values.
  • Interest-rate risk is material: approximately $1.892 billion of debt investments and $740.4 million of borrowings bore variable rates. The filing estimates that a 100-basis-point rate increase would raise annual net income by $11.5 million, and a 50-basis-point decrease would reduce it by $5.8 million, before incentive-fee and foreign-exchange effects.
  • PIK interest is non-cash when accrued but generally contributes to taxable income; the company warns this can require distributions without corresponding cash receipts. Foreign-currency exposure, borrower credit performance, valuation uncertainty and unfunded commitments are additional risks.
  • The Board declared a $0.26-per-share quarterly distribution on May 7, 2024, payable June 12, 2024. A new share-repurchase authorization permits up to $30 million of purchases below NAV through March 1, 2025; 115,911 shares were repurchased in Q1 at an average $9.56 per share.
  • The filing reports no material changes to previously disclosed risk factors and no material pending legal proceedings expected to affect results. It also identifies a €9.9 million guarantee related to MVC Automotive Group credit facilities maturing in December 2025.

Important facts for investors to verify

  • Reconcile the interest-rate swap fair value: the investment schedule and note report a liability of approximately $3.2 million, while MD&A describes a positive $3.2 million fair value.
  • Review non-accrual exposures, restructurings and recoverability—especially the newly non-accrual positions and investments with substantial cost-to-fair-value discounts.
  • Assess Level 3 valuation assumptions and concentration in equity and affiliated/control investments; the filing says no single investment exceeds 10% of portfolio fair value.
  • Monitor leverage, asset coverage, facility availability and near-term maturities, including the facility’s end of revolving period in February 2025 and 2025 note maturities.
  • Evaluate the cash coverage of distributions and the effect of PIK income, unfunded commitments and possible guarantee payments on liquidity.